Pentose Phosphate Pathway Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Pentose Phosphate Pathway. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Pentose Phosphate Pathway Indian Medical PG Question 1: Which is not a feature of G6PD deficiency?
- A. Presence of Heinz bodies
- B. Males and females are equally affected (Correct Answer)
- C. Absence of NADPH
- D. Oxidative stress
Pentose Phosphate Pathway Explanation: ***Males and females are equally affected***
- G6PD deficiency is an **X-linked recessive disorder**, meaning males are predominantly and more severely affected because they have only one X chromosome [2].
- Females are typically carriers and are less commonly affected, or may experience milder symptoms, due to **X-chromosome inactivation** (Lyonization).
*Presence of Heinz bodies*
- **Heinz bodies** are formed from denatured hemoglobin precipitates within red blood cells, a characteristic feature of **oxidative stress** in G6PD deficiency [2].
- These bodies are removed by the spleen, contributing to **hemolytic anemia**.
*Absence of NADPH*
- G6PD is the rate-limiting enzyme in the **pentose phosphate pathway**, which generates **NADPH** [1], [2].
- Without sufficient G6PD, the production of **NADPH** is severely impaired, leading to a deficiency in this critical reducing agent.
*Oxidative stress*
- **NADPH** is crucial for reducing **glutathione**, which in turn detoxifies reactive oxygen species [2].
- The lack of NADPH makes red blood cells vulnerable to **oxidative damage**, manifesting as hemolytic anemia upon exposure to oxidative agents [3].
Pentose Phosphate Pathway Indian Medical PG Question 2: Which of the following statements is true regarding the pentose phosphate pathway?
- A. Glucose is the only substrate that can enter this pathway
- B. The pentose phosphate pathway is a direct oxidative pathway of glucose metabolism (Correct Answer)
- C. The pathway has only monophosphates as intermediates
- D. None of the options
Pentose Phosphate Pathway Explanation: ***The pentose phosphate pathway is a direct oxidative pathway of glucose metabolism***
- The pathway **oxidizes glucose-6-phosphate** to generate **NADPH** and **pentose phosphates**, notably ribose-5-phosphate.
- It is considered "direct oxidative" because it bypasses the initial steps of glycolysis to produce these crucial products.
- The oxidative phase directly converts glucose-6-phosphate through two irreversible NADPH-generating steps.
*Glucose is the only substrate that can enter this pathway*
- While **glucose-6-phosphate** is the primary entry point, other intermediates from glycolysis can be channeled into the non-oxidative phase.
- For example, **fructose-6-phosphate** and **glyceraldehyde-3-phosphate** can be interconverted with pentose phosphates, allowing their entry.
*The pathway has only monophosphates as intermediates*
- The pathway involves various intermediates, including **sugar phosphates** like ribulose-5-phosphate, xylulose-5-phosphate, and sedoheptulose-7-phosphate.
- Many of these are **phosphates of different sugar lengths**, not exclusively monophosphates in the strict sense.
*None of the options*
- This statement is incorrect because the option regarding the pentose phosphate pathway being a **direct oxidative pathway of glucose metabolism** is accurate.
- The pathway's central role involves both the oxidative production of **NADPH** and the non-oxidative interconversion of sugars.
Pentose Phosphate Pathway Indian Medical PG Question 3: Which coenzyme is required by 6-phosphogluconate dehydrogenase?
- A. FAD
- B. NADP (Correct Answer)
- C. FMN
- D. NAD
Pentose Phosphate Pathway Explanation: ***Correct NADP***
- **6-phosphogluconate dehydrogenase** is a key enzyme in the **oxidative phase of the pentose phosphate pathway**, which generates **NADPH**.
- **NADP+** acts as an electron acceptor, getting reduced to **NADPH**, which is crucial for reductive biosynthesis and **antioxidant defense**.
*Incorrect FAD*
- **Flavin adenine dinucleotide (FAD)** is a derivative of **riboflavin (vitamin B2)** and is typically involved in reactions transferring two electrons, often found in **dehydrogenases** that form carbon-carbon double bonds.
- Enzymes like **succinate dehydrogenase** (in the TCA cycle) utilize **FAD**, which is not the case for 6-phosphogluconate dehydrogenase.
*Incorrect FMN*
- **Flavin mononucleotide (FMN)**, also derived from **riboflavin**, is primarily found in **flavoproteins** and acts as a prosthetic group in various **redox reactions**.
- It is a component of **Complex I (NADH dehydrogenase)** in the electron transport chain, but not involved in the pentose phosphate pathway's 6-phosphogluconate dehydrogenase reaction.
*Incorrect NAD*
- **Nicotinamide adenine dinucleotide (NAD+)** is a coenzyme primarily involved in catabolic reactions where it accepts electrons and is reduced to **NADH**, typically in glycolysis, the TCA cycle, and fatty acid oxidation.
- While structurally similar to NADP+, **NAD+** is involved in ATP production, whereas **NADP+** is used in anabolic processes.
Pentose Phosphate Pathway Indian Medical PG Question 4: Which enzyme is primarily associated with the reduction of NADP+ to NADPH in the pentose phosphate pathway?
- A. G6PD (Correct Answer)
- B. APDH
- C. α-keto glutarate dehydrogenases
- D. None of the options
Pentose Phosphate Pathway Explanation: ***G6PD***
- **Glucose-6-phosphate dehydrogenase (G6PD)** catalyzes the first committed step in the pentose phosphate pathway, converting **glucose-6-phosphate** to **6-phosphogluconolactone**.
- This reaction involves the reduction of **NADP+ to NADPH**, making G6PD the primary enzyme for NADPH production in this pathway.
*APDH*
- **APDH (adenosine phosphosulfate reductase)** is involved in sulfur metabolism and has no direct role in the pentose phosphate pathway or NADPH production.
- This enzyme primarily functions in prokaryotes for the **reduction of APS (adenosine 5'-phosphosulfate)**.
*α-keto glutarate dehydrogenases*
- **Alpha-ketoglutarate dehydrogenase** is a mitochondrial enzyme part of the **Krebs cycle**, converting **alpha-ketoglutarate to succinyl-CoA**.
- This enzyme is crucial for ATP production and generates **NADH**, not NADPH, in its reaction.
*None of the options*
- This option is incorrect because **G6PD** is indeed the primary enzyme responsible for NADPH generation in the pentose phosphate pathway.
Pentose Phosphate Pathway Indian Medical PG Question 5: Which of the following substances does not inhibit glycolysis?
- A. Fluoride
- B. Arsenite
- C. Iodoacetate
- D. Fluoroacetate (Correct Answer)
Pentose Phosphate Pathway Explanation: ***Fluoroacetate***
- **Fluoroacetate** is not a direct inhibitor of glycolysis. Instead, it is metabolized to **fluorocitrate**, which then acts as an inhibitor of **aconitase** in the **Krebs cycle (TCA cycle)**, thereby affecting cellular respiration at a later stage.
- Its primary role in metabolic inhibition is within the **mitochondria**, impacting energy production via the TCA cycle rather than the glycolytic pathway.
*Fluoride*
- **Fluoride** is a known inhibitor of **enolase**, an enzyme in the penultimate step of glycolysis.
- It forms a complex with **magnesium** and **phosphate** to block the active site of enolase, preventing the conversion of 2-phosphoglycerate to phosphoenolpyruvate.
*Arsenite*
- **Arsenite** inhibits glycolysis by targeting enzymes containing **sulfhydryl (–SH) groups**, particularly **glyceraldehyde-3-phosphate dehydrogenase (GAPDH)**, a critical enzyme in the glycolytic pathway.
- It also inhibits the **pyruvate dehydrogenase complex** (linking glycolysis to the TCA cycle) and TCA cycle enzymes like **α-ketoglutarate dehydrogenase**, thereby affecting multiple stages of cellular respiration.
*Iodoacetate*
- **Iodoacetate** is a potent inhibitor of the enzyme **glyceraldehyde-3-phosphate dehydrogenase (GAPDH)**.
- It specifically alkylates the **cysteine residue** at the active site of GAPDH, preventing the conversion of glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate, thereby blocking glycolysis.
Pentose Phosphate Pathway Indian Medical PG Question 6: Which compound serves as a central metabolic intermediate that connects glycolysis with glycogenesis and glycogenolysis?
- A. Glucose 1,6-bisphosphate
- B. Glucose 1-phosphate
- C. Glucose 6-phosphate (Correct Answer)
- D. Fructose 1,6-bisphosphate
Pentose Phosphate Pathway Explanation: ***Glucose 6-phosphate***
- **Glucose 6-phosphate** is the central metabolic hub connecting glycolysis, glycogenesis, and glycogenolysis
- Can be **isomerized to fructose 6-phosphate** to enter glycolysis for energy production
- Can be **converted to glucose 1-phosphate** via phosphoglucomutase for glycogen synthesis (glycogenesis)
- During **glycogenolysis**, it is formed from glucose 1-phosphate and can either enter glycolysis or be dephosphorylated to free glucose (in liver) for release into bloodstream
- This unique position makes it the **key branch point** connecting all three pathways
*Glucose 1,6-bisphosphate*
- Acts as a **cofactor for phosphoglucomutase enzyme**, facilitating the interconversion between glucose 1-phosphate and glucose 6-phosphate
- Not a direct metabolic intermediate in the main pathways
- Present in trace amounts and functions catalytically rather than as a pathway substrate
*Glucose 1-phosphate*
- Direct product of **glycogen breakdown** (glycogenolysis) via glycogen phosphorylase
- Must be **converted to glucose 6-phosphate** by phosphoglucomutase before entering glycolysis
- Converted to **UDP-glucose** for glycogen synthesis (glycogenesis)
- Does not directly connect all three pathways as it requires conversion to G6P first
*Fructose 1,6-bisphosphate*
- Committed intermediate **exclusively in glycolysis**, formed by phosphofructokinase-1 (PFK-1)
- Represents the **committed step** in glycolysis (irreversible under physiological conditions)
- Does not participate in glycogenesis or glycogenolysis
- Located downstream of the branch point, after pathway commitment
Pentose Phosphate Pathway Indian Medical PG Question 7: What cofactor is required for the proper functioning of glucose-6-phosphate dehydrogenase?
- A. NAD
- B. NADP (Correct Answer)
- C. FAD
- D. FMN
Pentose Phosphate Pathway Explanation: ***NADP***
- **NADP+** (nicotinamide adenine dinucleotide phosphate) acts as the **electron acceptor** in the **glucose-6-phosphate dehydrogenase (G6PD)** reaction, becoming **NADPH**.
- **NADPH** is crucial for maintaining the **redox balance** in cells, particularly in red blood cells, by reducing **oxidative stress**.
*NAD*
- **NAD+** (nicotinamide adenine dinucleotide) is a primary cofactor for many **dehydrogenase reactions** in catabolic pathways like **glycolysis** and the **Krebs cycle**.
- It primarily functions as an electron acceptor in pathways that generate **ATP**, distinct from the role of **NADPH** in reductive biosynthesis and antioxidant defense.
*FAD*
- **FAD** (flavin adenine dinucleotide) is a coenzyme derived from **riboflavin (vitamin B2)** that is involved in various redox reactions, often in the form of **flavoproteins**.
- Enzymes like **succinate dehydrogenase** in the electron transport chain utilize **FAD** as an electron acceptor, which is not the case for G6PD.
*FMN*
- **FMN** (flavin mononucleotide) is another coenzyme derived from **riboflavin**, structurally similar to FAD but lacking the additional adenosine monophosphate.
- It participates in electron transfer reactions, particularly within **complex I** of the **electron transport chain**, but is not a cofactor for G6PD.
Pentose Phosphate Pathway Indian Medical PG Question 8: A patient with hemolytic anemia has a defect in the enzyme glucose-6-phosphate dehydrogenase. Which of the following pathways is directly affected by this defect?
- A. Glycolysis
- B. Pentose phosphate pathway (Correct Answer)
- C. TCA cycle
- D. Urea cycle
Pentose Phosphate Pathway Explanation: ***Pentose phosphate pathway***
- **Glucose-6-phosphate dehydrogenase (G6PD)** is the **rate-limiting enzyme** in the **pentose phosphate pathway (PPP)**, initiating the oxidative phase.
- Deficiency in G6PD impairs the production of **NADPH**, which is crucial for reducing **oxidative stress** in red blood cells.
*Glycolysis*
- This pathway metabolizes glucose to pyruvate for **ATP production** and does not directly involve G6PD.
- While G6P is an intermediate in both pathways, its conversion in glycolysis is catalyzed by phosphoglucose isomerase, not G6PD.
*TCA cycle*
- The **tricarboxylic acid (TCA) cycle** is a central metabolic pathway for energy production occurring in the **mitochondria**.
- It involves the oxidation of acetyl-CoA and does not directly utilize G6PD.
*Urea cycle*
- The **urea cycle** is responsible for detoxifying ammonia by converting it into urea, primarily occurring in the **liver**.
- This pathway is unrelated to glucose metabolism or G6PD activity.
Pentose Phosphate Pathway Indian Medical PG Question 9: Riboflavin deficiency is assessed by?
- A. None of the options
- B. Glutathione reductase activity (Correct Answer)
- C. Pyruvate dehydrogenase activity
- D. Transketolase activity
Pentose Phosphate Pathway Explanation: ***Glutathione reductase activity***
- Riboflavin is a precursor to **flavin adenine dinucleotide (FAD)**, a coenzyme for **glutathione reductase**.
- Reduced glutathione reductase activity and its activation coefficient in erythrocytes are reliable indicators of **riboflavin deficiency**.
*Pyruvate dehydrogenase activity*
- **Pyruvate dehydrogenase** complex requires **thiamine pyrophosphate** (from thiamine, vitamin B1), not riboflavin, as a coenzyme.
- Its activity is used to assess **thiamine status**, not riboflavin.
*None of the options*
- This option is incorrect as **glutathione reductase activity** is a valid method for assessing riboflavin deficiency.
- The other options provided target different vitamin deficiencies.
*Transketolase activity*
- **Transketolase** activity is specifically used to assess **thiamine (vitamin B1) status**.
- It requires **thiamine pyrophosphate** as a coenzyme, which is derived from thiamine.
Pentose Phosphate Pathway Indian Medical PG Question 10: Which of the following is not the source of cytosolic NADPH:
- A. ATP citrate lyase (Correct Answer)
- B. G6PD
- C. Malic enzyme
- D. Isocitrate dehydrogenase
Pentose Phosphate Pathway Explanation: ***ATP citrate lyase***
- **ATP citrate lyase** is an enzyme that converts **citrate** and **CoA** into **acetyl-CoA** and **oxaloacetate** in the cytoplasm.
- This enzyme is crucial for fatty acid synthesis but does not directly produce **NADPH**.
*G6PD*
- **Glucose-6-phosphate dehydrogenase (G6PD)** is the rate-limiting enzyme of the **pentose phosphate pathway**.
- It catalyzes the first step, producing **NADPH** during the conversion of glucose-6-phosphate to 6-phosphogluconolactone.
*Malic enzyme*
- **Malic enzyme** converts **malate** to **pyruvate**, generating **NADPH** in the cytosol.
- This reaction helps to replenish cytosolic **NADPH** needed for lipid biosynthesis and other reductive processes.
*Isocitrate dehydrogenase*
- In the cytoplasm, the **cytosolic isocitrate dehydrogenase** isoform oxidizes **isocitrate** to **α-ketoglutarate**.
- This reaction generates **NADPH**, which is vital for reductive biosynthesis and antioxidant defense.
More Pentose Phosphate Pathway Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
